Dr. Carole Bitar, MD

Dr. Bitar practices at Tulane University Medical Group in New Orleans, Louisiana.

Dr. Bitar's NPI, 1194131904, was assigned on July 1, 2014. Dr. Bitar holds Louisiana license 329021.

Dr. Bitar's primary practice is Tulane University Medical Group, at 1430 Tulane Ave, New Orleans, LA 70112 in Orleans Parish. The practice phone is (504) 988-2300.

Dr. Bitar's primary practice is Tulane University Medical Group in New Orleans, Louisiana. Dr. Bitar is also affiliated with University Medical Center New Orleans. The medical group on file is Tulane Doctors. Dmand AI also links Dr. Bitar to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bitar practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatopathology is Dr. Bitar's primary specialty in the NPI Registry, under taxonomy code 207ND0900X. Dr. Bitar is licensed in Louisiana.

CMS data shows 1,091 Medicare services from Dr. Bitar across 12 procedure codes in 2024, for 210 Medicare patients. Medicare paid $40,817 for them.

CMS counts 210 Medicare patients who saw Dr. Bitar in 2024. The largest group is 65 to 74, with 108 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bitar's median patient age at 68, with 57% women.

In 2024, Dr. Bitar wrote 1,089 Medicare Part D claims for 202 patients. 75% of them were for generic drugs. CMS names the drug for 922 of them, across 24 drugs with 11 or more claims each, at $1,330,577 in total drug cost. In 2023, CMS named 576 claims across 21 drugs.

Dr. Bitar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 188 procedures of removal of skin lesions by Dr. Bitar, more than 79% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 25 papers to Dr. Bitar, published from 2013 to 2025. 2021 was the busiest year, with 3. The most frequent topics are Skin Neoplasms, Skin and Ankle. Dr. Bitar has published most often in Am J Dermatopathol. Dr. Bitar's most frequent co-authors are Erin Elizabeth Boh, MD, PhD, Nakhle Saadallah Saba, MD and Aleodor Alexandru Andea, MD.

CMS Open Payments shows 62 general payments to Dr. Bitar from 13 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 97% of the total. Bristol-Myers Squibb Company paid the most, $404.